NewGam

intravenous immunoglobulin · Octapharma

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NewGam, covering 2017-02-23 to 2021-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy [Phase 3]

See pricing